Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Thorac Cancer ; 12(12): 1900-1908, 2021 06.
Article in English | MEDLINE | ID: mdl-33982884

ABSTRACT

BACKGROUND: The cylindromatosis (CYLD) tumor suppressor is a microtubule-associated deubiquitinase that plays a critical role in the regulation of cell signaling and contributes to a variety of physiological and pathological processes. However, the functions of CYLD in zebrafish are less well known, particularly with regard to their development and physiology. In this context, we investigated the loss of function of CYLD in zebrafish via transcription activator-like effector nuclease (TALEN)-based gene deletion. METHODS: Semi-quantitative RT-PCR was used to quantify CYLD mRNA expression in zebrafish embryos at various developmental stages. We also performed whole-mount in situ hybridization to further assess the dynamic expression and distribution of CYLD in the entire zebrafish embryos at different stages. In addition, we deleted CYLD in zebrafish with TALENs to investigate its potential impact on embryonic development. RESULTS: The expression of CYLD mRNA varied during early embryonic development. The CYLD mRNA localized to the brain and notochord of developing zebrafish embryos. Homozygous deletion of CYLD resulted in embryonic death before 8 h post-fertilization. CONCLUSIONS: CYLD appears to play an important role in central nervous system development in zebrafish. Although severe embryonic death restricted analysis of homozygous mutants, further research into the role of CYLD in central nervous system development is warranted.


Subject(s)
Brain/growth & development , Deubiquitinating Enzyme CYLD/metabolism , Notochord/growth & development , Animals , Brain/metabolism , Deubiquitinating Enzyme CYLD/genetics , Humans , Notochord/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Zebrafish
2.
Exp Cell Res ; 387(1): 111776, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31838060

ABSTRACT

Microtubule-binding proteins provide an alternative and vital pathway to the functional diversity of microtubules. Considerable work is still required to understand the complexities of microtubule-associated cellular processes and to identify novel microtubule-binding proteins. In this study, we identify Bcl2-associated athanogene cochaperone 6 (BAG6) as a novel microtubule-binding protein and reveal that it is crucial for primary ciliogenesis. By immunofluorescence we show that BAG6 largely colocalizes with intracellular microtubules and by co-immunoprecipitation we demonstated that it can interact with α-tubulin. Additionally, both the UBL and BAG domains of BAG6 are indispensable for its interaction with α-tubulin. Moreover, the assembly of primary cilia in RPE-1 cells is significantly inhibited upon the depletion of BAG6. Notably, BAG6 inhibition leads to an abnormal G0/G1 transition during the cell cycle. In addition, BAG6 colocalizes and interactes with the centrosomal protein γ-tubulin, suggesting that BAG6 might regulate primary ciliogenesis through its action in centrosomal function. Collectively, our findings suggest that BAG6 is a novel microtubule-bindng protein crucial for primary ciliogenesis.


Subject(s)
Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Molecular Chaperones/metabolism , Tubulin/metabolism , Carrier Proteins/metabolism , Cell Line , Cell Line, Tumor , G1 Phase/physiology , HEK293 Cells , HeLa Cells , Humans , Protein Binding/physiology , Resting Phase, Cell Cycle/physiology
3.
IUBMB Life ; 70(10): 976-984, 2018 10.
Article in English | MEDLINE | ID: mdl-30212601

ABSTRACT

This study investigated the effect of muscle-derived stem cells (MDSCs) and adipose tissue-derived stem cells (ADSCs) in the treatment of stress urinary incontinence (SUI) and their differences in a rat model. MDSCs and ADSC were isolated from rats (n = 10), examined for their properties, and labeled with enhanced green fluorescent protein (EGFP) and ß-galactosidase (ß-gal) gene. Rats received bladder-neck and transurethral sphincter injection of EGFP-labeled MDSCs and ß-gal gene-labeled ADSC and injection of D-Hanks as a control (n = 24 each group). At 0, 15, 30, and 60 days after cells injection, urinary voiding function was assessed by urine dynamics detector. The rats were killed to harvest their urethras for tracking of MDSCs and ADSC. Western blotting and quantitative real-time reverse transcription PCR (qRT-PCR) was performed to detect smooth muscle contents. Urodynamic test showed that MDSCs and ADSC improved the function of urination in rats with intrinsic sphincter deficiency (ISD), and effect of MDSCs-treatment was more pronounced. In addition, histologic analysis showed that the MDSCs and ADSC-treated groups had significantly higher myosin and α-smooth muscle actin (α-SMA) content than the control group. Compared with ADSC-treated groups, the MDSCs-treated groups in myosin and α-SMA content showed the tendency of increase. In summary, MDSCs and ADSCs have obvious effects in the treatment and/or prevention of ISD and transplantation of MDSCs is more effective than ADSC. © 2018 IUBMB Life, 70(10):976-984, 2018.


Subject(s)
Mesenchymal Stem Cells , Muscle, Skeletal/transplantation , Stem Cell Transplantation , Urinary Incontinence, Stress/therapy , Actins/metabolism , Animals , Disease Models, Animal , Green Fluorescent Proteins/administration & dosage , Green Fluorescent Proteins/chemistry , Humans , Injections , Muscle, Skeletal/cytology , Muscle, Smooth/metabolism , Muscle, Smooth/pathology , Myoblasts/cytology , Myoblasts/transplantation , Myosins/metabolism , Rats , Urethra/pathology , Urinary Incontinence, Stress/genetics , Urinary Incontinence, Stress/urine
4.
Thorac Cancer ; 6(5): 649-54, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26445615

ABSTRACT

Microtubule-binding proteins (MBPs) are structurally and functionally diverse regulators of microtubule-mediated cellular processes. Alteration of MBPs has been implicated in the pathogenesis of human diseases, including cancer. MBPs can stabilize or destabilize microtubules or move along microtubules to transport various cargoes. In addition, MBPs can control microtubule dynamics through direct interaction with microtubules or coordination with other proteins. To better understand microtubule structure and function, it is necessary to identify additional MBPs. In this study, we isolated microtubules and MBPs from mammalian cells by a taxol-based method and then profiled a panel of MBPs by mass spectrometry. We discovered a number of previously uncharacterized MBPs, including several membrane-associated proteins and proteins involved in post-translational modifications, in addition to several structural components. These results support the notion that microtubules have a wide range of functions and may undergo more exquisite regulation than previously recognized.

5.
J Proteome Res ; 14(8): 3292-304, 2015 Aug 07.
Article in English | MEDLINE | ID: mdl-26165356

ABSTRACT

Tubulin is known to undergo unique post-translational modifications (PTMs), such as detyrosination and polyglutamylation, particularly in the unstructured carboxy-terminal tails (CTTs). However, more conventional PTMs of tubulin and their roles in the regulation of microtubule properties and functions remain poorly defined. Here, we report the comprehensive profiling of tubulin phosphorylation, acetylation, ubiquitylation, and O-GlcNAcylation in HeLa cells with a proteomic approach. Our tubulin-targeted analysis has identified 80 residues bearing single or multiple conventional PTMs including 24 novel PTM sites not covered in previous global proteomic surveys. By using a series of PTM-deficient or PTM-mimicking mutants, we further find that tubulin phosphorylation and acetylation play important roles in the control of microtubule assembly and stability. In addition, these tubulin PTMs have distinct effects on the retrograde transport of adenoviruses along microtubules. These findings thus enlarge the repertoire of tubulin PTMs and foster our understanding of their versatile roles in the regulation of microtubule dynamics and cellular functions.


Subject(s)
Microtubules/metabolism , Protein Processing, Post-Translational , Proteomics/methods , Tubulin/metabolism , Acetylation , Amino Acid Sequence , Binding Sites/genetics , Chromatography, Liquid , Glycosylation , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HeLa Cells , Humans , Immunoblotting , Mass Spectrometry , Microscopy, Fluorescence , Microtubules/genetics , Models, Molecular , Molecular Sequence Data , Phosphorylation , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Tubulin/chemistry , Tubulin/genetics , Ubiquitination
6.
Cancer Biol Ther ; 15(11): 1561-70, 2014.
Article in English | MEDLINE | ID: mdl-25482939

ABSTRACT

Neuroblastoma is one of the most prevalent pediatric extracranial solid tumors and is often diagnosed after dissemination has occurred. Despite recent advances in multimodal therapies of this malignancy, its therapeutic efficacy remains poor. Novel treatment strategies are thus in great need. Herein, we demonstrate that histone deacetylase 6 (HDAC6), a member of the deacetylase family that is localized predominantly in the cytoplasm, is involved in neuroblastoma dissemination. HDAC6 expression in neuroblastoma tissue samples varied with the site of the tumor. HDAC6 showed little impact on the proliferation of neuroblastoma cells. Instead, downregulation of HDAC6 expression by RNA interference or inhibition of its catalytic activity by the pharmacological inhibitor tubacin significantly decreased the migration of 3 human malignant neuroblastoma cell lines and reduced the invasion ability of one of the 3 cell lines, but only slightly affected the migration and invasion of human normal brain glial cells. Our data further revealed that the regulation of neuroblastoma cell migration by HDAC6 was mediated by its effects on cell polarization and adhesion. These findings suggest a role for HDAC6 in neuroblastoma dissemination and a potential of using HDAC6 inhibitors for the treatment of this malignancy.


Subject(s)
Cell Movement , Histone Deacetylases/metabolism , Neuroblastoma/metabolism , Neuroblastoma/pathology , Cell Adhesion , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation , Down-Regulation , Enzyme Activation , Gene Expression , Histone Deacetylase 6 , Histone Deacetylases/genetics , Humans , Immunohistochemistry , Neoplasm Invasiveness , Neuroblastoma/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism
7.
PLoS One ; 9(4): e94496, 2014.
Article in English | MEDLINE | ID: mdl-24718556

ABSTRACT

The innate immune system is the first line of host defense against infection and involves several different cell types. Here we investigated the role of the phosphatidylinositol 3 kinase (PI3K) signaling pathway in innate immune cells. By blocking this pathway with pharmacological inhibitors, we found that the production of proinflammatory cytokines was drastically suppressed in monocytes and macrophages. Further study revealed that the suppression was mainly related to the mammalian target of rapamycin (mTOR)/p70(S6K) signaling. In addition, we found that the PI3K pathway was involved in macrophage motility and neovascularization. Our data provide a rationale that inhibition of the PI3K signaling pathway could be an attractive approach for the management of inflammatory disorders.


Subject(s)
Immunity, Innate , Macrophages/enzymology , Monocytes/enzymology , Phosphatidylinositol 3-Kinase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , TOR Serine-Threonine Kinases/metabolism , Cell Adhesion/drug effects , Cell Line , Cell Movement/drug effects , Cytokines/metabolism , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Humans , Immunity, Innate/drug effects , Inflammation Mediators/metabolism , Macrophages/cytology , Macrophages/drug effects , Monocytes/cytology , Monocytes/drug effects , Neovascularization, Physiologic/drug effects , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Signal Transduction/drug effects , Vascular Endothelial Growth Factor A/metabolism
8.
Atherosclerosis ; 233(2): 403-409, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24530770

ABSTRACT

OBJECTIVE: Atherosclerosis and other cardiovascular diseases are serious threats to human health and become the leading cause of death in the world. Emerging evidence reveals that inhibition of plaque neovascularization could be an effective approach for the treatment of atherosclerosis. This study was conducted to identify cytoplasmic linker protein 170 as a potential target for cardiovascular diseases through modulation of neovascularization. METHODS AND RESULTS: Immunofluorescence microscopy revealed that cytoplasmic linker protein 170 was ubiquitously expressed in mouse kidney, liver, lung, normal non-atherosclerotic aorta, and atherosclerotic aorta and was partly localized in the vascular endothelium. siRNAs were introduced to human umbilical vein endothelial cells (HUVECs) and the effect of knockdown was confirmed by Western blotting. Vascularization study was assessed with matrigel-based capillary assembly, branching, and in vivo matrigel plug assays. The data showed that siRNA-mediated knockdown of the cytoplasmic linker protein remarkably compromised the assembly and branching of capillary-like blood vessels and neovascularization in vivo. Cell motility and polarity properties were then analyzed using scratch wound repair, boyden chamber, and immunofluorescence assays, and the results revealed that the cytoplasmic linker protein was critical for the motility abilities of HUVECs through its actions on cell polarity. CONCLUSION: Both in vitro and in vivo studies demonstrate the significance of the cytoplasmic linker protein for blood vessel formation. Mechanistic investigation reveals that its effect on neovascularization is orchestrated through its regulation of vascular endothelial cell polarity and motility. These findings provide the basis for exploring effective approaches to regulate neovascularization in cardiovascular diseases.


Subject(s)
Microtubule-Associated Proteins/physiology , Neoplasm Proteins/physiology , Neovascularization, Pathologic/prevention & control , Animals , Atherosclerosis/etiology , Capillaries/growth & development , Cell Movement/drug effects , Cell Polarity/drug effects , Collagen , Dietary Fats/toxicity , Drug Combinations , Endothelial Cells/cytology , Endothelium, Vascular/physiology , Female , Gene Knockdown Techniques , Human Umbilical Vein Endothelial Cells , Humans , Laminin , Mice , Microtubule-Associated Proteins/antagonists & inhibitors , Molecular Targeted Therapy , Neoplasm Proteins/antagonists & inhibitors , Neovascularization, Pathologic/physiopathology , Organ Specificity , Plaque, Atherosclerotic/drug therapy , Plaque, Atherosclerotic/physiopathology , Proteoglycans , RNA, Small Interfering/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...